Anterogen.Co.,Ltd. (065660.KQ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−58.2x

Market Cap

KRW 147.14B

MomentumView details →

1D Return

−0.34%

YTD Return

−67.73%

RSI (14)

42.3

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−58.2x

Market Cap

KRW 147.14B

RSI (14)

42.3

MomentumView details →

1D Return

−0.34%

YTD Return

−67.73%

ProfitabilityView details →

Gross Margin

29.73%

Net Margin

−19.32%

EBITDA Margin

−21.44%

ROE (TTM)

−2.01%

ROA (TTM)

−1.96%

Asset Turnover

0.10x

GrowthView details →

Revenue YoY

+16.55%

EPS YoY

+20.74%

FCF YoY

+37.23%

Revenue CAGR 3Y

+4.57%

EPS CAGR 3Y

+53.16%

EBITDA YoY

−14.70%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

24.69x

Quick Ratio

23.50x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

8.37B

Net Income (TTM)

−1.62B

Op. CF (TTM)

−1.11B

Latest newsMore news →

No recent news for 065660.KQ.

Similar companies

Genexine, Inc.095700.KQ Vertex Pharmaceuticals IncorporatedVRTX Helixmith Co., Ltd084990.KQ Macrogen, Inc.038290.KQ HLB Therapeutics Co.,Ltd.115450.KQ Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.06990.HK Find similar companies →

Latest newsMore news →

No recent news for 065660.KQ.